Yanli Xu
机构：Capital Medical University, First Affiliated Hospital of Guangzhou Medical University, Guangzhou Blood Center, Guangzhou First People's Hospital, Beijing Ditan Hospital, Guangzhou Medical University
发表论文 13 篇 · 总被引 104 次 · h-index 5
代表论文
- Biochemical Characterization of dTDP- d -Qui4N and dTDP- d -Qui4NAc Biosynthetic Pathways in Shigella dysenteriae Type 7 and Escherichia coli O7 (2007 · Journal of Bacteriology · 被引 32)
- Reciprocal regulation between O-GlcNAcylation and tribbles pseudokinase 2 (TRIB2) maintains transformative phenotypes in liver cancer cells (2016 · Cellular Signalling · 被引 26)
- Contrast-Enhanced Ultrasound for the Diagnosis of Hepatic Adenoma (2011 · Journal of International Medical Research · 被引 15)
- Ningetinib, a novel FLT3 inhibitor, overcomes secondary drug resistance in acute myeloid leukemia (2024 · Cell Communication and Signaling · 被引 9)
- Innovative evaluation of selinexor and JQ1 synergy in leukemia therapy via C-MYC inhibition (2025 · Journal of Translational Medicine · 被引 6)
- Regulating the Wnt/β‐catenin Signaling Pathway Promotes Repigmentation in Vitiligo Using Fire Needle Therapy (2024 · Dermatologic Therapy · 被引 5)